CIK 0001425205 · Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753254381
- Phone
- 6502607120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-16 | Puri Raj K. Chief Regulatory Officer | Grant or award · Restricted Stock Units | +15,000 | 15,000 | ||
| 2026-06-05 | Vogt Frederick G Interim CEO & General Counsel | Option exercise | +15,625 | 569,130 | ||
| 2026-06-05 | Vogt Frederick G Interim CEO & General Counsel | Shares withheld for taxes | −6,638 | $4.23 | $28K | 562,492 |
| 2026-06-05 | Vogt Frederick G Interim CEO & General Counsel | Option exercise · Restricted Stock Units | −15,625 | 109,382 | ||
| 2026-06-05 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise | +7,813 | 144,087 | ||
| 2026-06-05 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Shares withheld for taxes | −3,976 | $4.23 | $17K | 140,111 |
| 2026-06-05 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise · Restricted Stock Units | −7,813 | 54,691 | ||
| 2026-06-05 | Puri Raj K. Chief Regulatory Officer | Option exercise | +9,766 | 251,957 | ||
| 2026-06-05 | Puri Raj K. Chief Regulatory Officer | Shares withheld for taxes | −3,843 | $4.23 | $16K | 248,114 |
| 2026-06-05 | Puri Raj K. Chief Regulatory Officer | Option exercise · Restricted Stock Units | −9,766 | 68,365 | ||
| 2026-06-05 | BILINSKY IGOR Chief Operating Officer | Option exercise | +7,813 | 137,896 | ||
| 2026-06-05 | BILINSKY IGOR Chief Operating Officer | Shares withheld for taxes | −3,976 | $4.23 | $17K | 133,920 |
| 2026-06-05 | BILINSKY IGOR Chief Operating Officer | Option exercise · Restricted Stock Units | −7,813 | 54,691 | ||
| 2026-06-01 | Vogt Frederick G Interim CEO & General Counsel | Option exercise | +41,668 | 571,206 | ||
| 2026-06-01 | Vogt Frederick G Interim CEO & General Counsel | Shares withheld for taxes | −17,701 | $3.96 | $70K | 553,505 |
| 2026-06-01 | Vogt Frederick G Interim CEO & General Counsel | Option exercise · Restricted Stock Units | −41,668 | 125,007 | ||
| 2026-06-01 | Puri Raj K. Chief Regulatory Officer | Option exercise | +5,469 | 244,699 | ||
| 2026-06-01 | Puri Raj K. Chief Regulatory Officer | Shares withheld for taxes | −2,508 | $3.96 | $10K | 242,191 |
| 2026-06-01 | Puri Raj K. Chief Regulatory Officer | Option exercise · Restricted Stock Units | −5,469 | 16,409 | ||
| 2026-06-01 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise | +8,790 | 140,747 |
Page 3 of 14 · 280 trades